Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.80%
#2 Movement Movement +11.34%
#3 Victoria VR Victoria VR +7.37%
#4 DMT-NAT DMT-NAT +5.95%
#5 Cryptopia Cryptopia +5.23%
#6 COTI COTI +4.96%
#7 Lisk Lisk +4.73%
#8 Pons Pons +4.67%
#9 MarsCoin MarsCoin +4.33%
#10 Jito Jito +3.85%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.

Recordati Industria Chimica e Farmaceutica S.p.A.

REC
Kedudukan dalam Saham #1793
Recordati Industria Chimica e Farmaceutica S.p.A., together with its... Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops Maapliv for maple syrup urine disease; Isturia for endogenous Cushing’s syndrome; Cystadrops treatment of the ocular manifestations of cystinosis; Carbaglu for hyperammonemia due to n-acetyl glutamate synthase deficiency; Qarziba for neuroblastoma patients and patients with relapsed or refractory neuroblastoma; and Fotivda for renal cell carcinoma. It also develops Sylvant for idiopathic multicentric castleman diseases; Caphosol for oral mucositis; ENJAYMO for hemolysis in adults with cold agglutinin disease; Zanidip, Zanipress, Vazkepa, and Logimax for hypertension; Urorec and Avodart for symptoms of benign prostatic hyperplasia; and Livazo for dyslipidemia; Combodart/Duodart; Seloken for angina pectoris, myocardial infarction and cardiac rhythm disorders, as well as hypertension and functional heart disorders. In addition, the company offers Procto-Glyveno for internal and external hemorrhoids; Polydexa, Isofra, and Otofa for ear, nose and throat infections; Isturisa, for Cushing’s syndrome; Normosang, human hemin; Juxtapid, homozygous familial hypercholesterolemia;Ledaga, mycosis fungoides, T-cell cutaneous lymphoma;Tergynan, an anti-infective for gynecological infections; CitraFleet and Phosphosoda as bowel cleansers; Lomexin for gynecological and dermatological infections; Hexaspray, treatments for the oral cavity; Magnesio Supremo, a dietary supplement; Reaglia for schizophrenia; Eligard for hormone-dependent prostate cancer; and pasireotide in Phase II trial for patients with post-bariatric hypoglycemia, as well as other products. The company was founded in 1926 and is headquartered in Milan, Italy.
Harga Saham
$62.39
Disegerakkan terakhir: 2026-08-12
Modal Pasaran
$12.69B
Perubahan (1 hari)
-0.19%
Perubahan (1 tahun)
4.91%
Negara
IT
Perdagangan Recordati Industria Chimica e Farmaceutica S.p.A. (REC)

Kategori

Healthcare
Sejarah harga saham bagi Recordati Industria Chimica e Farmaceutica S.p.A. (REC)
Harga penutupan tertinggi: $62.63 pada 2026-08-01

Harga penutupan terendah: $0.31 pada 1995-01-01
Sejarah harga saham Recordati Industria Chimica e Farmaceutica S.p.A. dari 1995 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 3.85%
2025 6.40%
2024 3.94%
2023 20.93%
2022 -31.57%
2021 15.77%
2020 30.61%
2019 24.94%
2018 -26.09%
2017 61.19%
2016 8.52%
2015 54.66%
2014 18.56%
2013 55.80%
2012 21.25%
2011 -18.52%
2010 15.93%
2009 44.92%
2008 -40.59%
2007 21.62%
2006 6.93%
2005 21.39%
2004 18.17%
2003 13.54%
2002 -14.02%
2001 110.27%
2000 144.44%
1999 -78.32%
1998 154.19%
1997 8.77%
1996 106.55%
1995 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $59.08 62.03%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 $49.68 72.21%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 $184.45 43.36%
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $113.04 55.27%
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $0.63 -36.05%
HK